研究者情報 - 梅本久美子 | 聖マリアンナ医科大学

（最終更新日：2024-04-10 10:39:13）

  ウメモト　クミコ   UMEMOTO KUMIKO
  梅本久美子
   所属   医学部医学科臨床腫瘍学

職種講師

■ 学術雑誌

1.	総説・解説	Microsatellite instability: A 2024 update 2024/03
2.	原著	Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer 2024/02
3.	原著	The Phase I/II eNRGy Trial: Zenocutuzumab in Patients with Cancers Harboring NRG1 Gene Fusions 2024/02
4.	原著	Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas 2023/10
5.	総説・解説	Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment 2023/08
6.	原著	Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment 2023/06
7.	原著	Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer. 2023/05
8.	原著	Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer 2023/04
9.	原著	Efficacy of chemotherapy for patients with metastatic or recurrent pancreatic adenosquamous carcinoma: A multicenter retrospective analysis 2022/12
10.	原著	Nivolumab for treating patients with occupational cholangiocarcinoma 2022/11
11.	原著	Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer 2022/10
12.	原著	The molecular landscape of pancreatobiliary cancers for novel targeted therapies from real-world genomic profiling. 2022/05
13.	原著	Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers 2022/03
14.	原著	Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment 2022/03
15.	総説・解説	The potential targeted drugs for fusion genes including NRG1 in pancreatic cancer 2021/10
16.	原著	FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 28 and 6 polymorphism: a multicenter, retrospective study 2021/03
17.	原著	Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment 2021/03
18.	原著	Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer 2021/01
19.	症例報告	Inferior mesenteric arteriovenous fistula during treatment with bevacizumab in colorectal cancer patient: A case report 2020/11
20.	原著	The potential application of PD-1 blockade therapy for early-stage biliary tract cancer 2020/04
5件表示
全件表示(20件)

■ 著書

1.	部分執筆	肝細胞がん「新臨床腫瘍学改訂第7版」 2024/02
2.	部分執筆	若年膵癌とKRAS変異「胆と膵」 2023/07

■ 学会発表

1.	Characterization of patients with advanced biliary tract cancer by KRAS alteration subtypes （口頭発表） 2024/02/24
2.	Clinical significance of plasma-based comprehensive genomic profiling in metastatic colorectal cancer by RAS/BRAF status （口頭発表，一般） 2024/02/24
3.	患者と主治医の抗がん剤による副作用のつらさと休薬希望度の差に関する意識調査（口頭発表） 2024/02/24
4.	A feasibility study to evaluate clinical utility of stress data collection in cancer patients treated with chemotherapy （口頭発表） 2024/02/22
5.	Clinical course of skin rashes caused by neoadju-vant gemcitabine plus S-1 for resectable pancre-atic cancer （口頭発表） 2024/02/22
6.	Comprehensive clinico-molecular profile and efficacy of anti-HER2 therapy for HER2-amplified biliary tract cancer （ポスター） 2024/01
7.	Prognostic effects of co-occurring TP53 and KRAS aberrations in patients with advanced biliary tract cancer. （ポスター） 2024/01
8.	Safety and efficacy of chemotherapy for patients (pts) with unresectable pancreatic cancer (uPC) concomitant with collagen disease: A multicenter retrospective observational study （ポスター） 2024/01
9.	Durable efficacy of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion-positive (NRG1+) non-small cell lung cancer (NSCLC) （口頭発表） 2023/12/01
10.	センターの設置による胆道・膵臓病に対する多科および多職種連携（ポスター，一般） 2023/11/04
11.	切除不能または再発胆道癌患者に対する二次以降の薬物療法としてのFOLFOX療法の有効性及び安全性の検討（JON-2107B）（口頭発表） 2023/09
12.	切除可能膵頭部に対するNAC-GSについての現況と課題（口頭発表，一般） 2023/07/21
13.	A study to evaluate the clinical utility of stress data collection in cancer patients treated with chemotherapy （ポスター） 2023/03/17
14.	がん薬物療法患者におけるストレスデータ収集の有用性に関する研究（ポスター） 2023/03/17
15.	切除不能進行大腸癌におけるCDC37遺伝子発現のレゴラフェニブ療法の効果予測（口頭発表） 2023/03/16
16.	胃癌患者における免疫関連有害事象の予測因子としての自己免疫疾患関連抗体の臨床的意義（口頭発表） 2023/02/25
17.	Treatment for elderly gastric cancer patients-Geriatric assessment and clinical outcomes- （口頭発表） 2023/02/24
18.	切除可能膵頭部癌に対するNAC-GSについての現況と課題（口頭発表，一般） 2023/02/17
19.	胃癌ゲノムプロファイリングによるdruggable alterationの同定（口頭発表） 2023/02
20.	高齢胃癌患者における高齢者機能評価と臨床経過（口頭発表） 2023/02
21.	Outcomes of FOLFIRINOX and gemcitabine plus nab-paclitaxel in patients with early recurrent pancreatic cancer after adjuvant S-1: A propensity score–matching analysis. 2023/01/20
22.	Interim analysis results of gut microbiota in patients with unresectable cholangiopancreatic cancer: SCRUM-Japan MONSTAR-SCREEN. 2023/01/19
23.	リアルワールドデータ（RWD）から見た小腸癌のゲノムランドスケープ（口頭発表） 2022/10
24.	食道扁平上皮癌・胃食道接合部癌におけるctDNAを用いた治療戦略（口頭発表，シンポジウム・ワークショップ・パネルディスカッション等） 2022/09/25
25.	切除可能大腸がん高齢患者の高齢者機能評価と臨床経過（ポスター） 2022/06/18
26.	Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer (mCRC). （ポスター） 2022/06/04
27.	Efficacy and safety of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion-positive (NRG1+) cancer 2022/06/03
28.	Identification of an optimal circulating tumor DNA (ctDNA) shedding threshold to detect actionable driver mutations in colorectal and pancreatic adenocarcinoma. 2022/06/03
29.	遠隔医療を用いた治験プレスクリーニング検査の実装 2022/02/17
30.	Somatostatin receptor: a potential new therapeutic target for primary mucinous neoplasm of the appendix. （口頭発表） 2022/02
31.	Genomic landscape in small intestine cancer from real-world data (RWD) of clinical genomic testing. 2022/01/20
32.	Efficacy and safety of zenocutuzumab in advanced pancreatic cancer and other solid tumors harboring NRG1 fusions 2021/11/26
33.	Efficacy and safety of zenocutuzumab in advanced pancreatic cancer and other solid tumors harboring NRG1 fusions 2021/09/23
34.	進行膵癌におけるリキッドバイオプシーと、KRAS野生型膵癌の治療開発に関する取り組み 2021/09/22
35.	Genomic landscape in advanced gastric cancer from real-world data (RWD) of clinical genomic testing （ポスター，一般） 2021/09/21
36.	Efficacy and safety of zenocutuzumab in advanced pancreatic cancer and other solid tumors harboring NRG1 fusions 2021/06/04
37.	Genomic alterations for novel targeted therapies in pancreatobiliary cancers from real-world data （ポスター，一般） 2021/06/04
38.	進行固形がん患者における免疫チェックポイント阻害薬導入前の抗体検査と免疫関連有害事象との関連性 2021/02/19
39.	A translational study to evaluate genomic markers and concordance with circulating-tumor DNA and circulating tumor cells to predict clinical outcomes in gastrointestinal and pancreatobiliary cancers: Valor trial. （ポスター） 2021/01/15
40.	Efficacy of chemotherapy for patients with unresectable or recurrent pancreatic adenosquamous carcinoma: A multicenter retrospective analysis. 2021/01/15
41.	Multi-gene panel testing in patients with gastro-intestinal cancers: A retrospective study. （口頭発表，一般） 2020/10/23
42.	高齢者胃癌に対する治療の工夫（口頭発表，シンポジウム・ワークショップ・パネルディスカッション等） 2020/10/22
43.	血管新生阻害薬による化学療法中に下腸間膜動静脈瘻を合併した大腸癌症例（ポスター，一般） 2020/08/11
44.	Association of gastric acid suppression with efficacy of immune checkpoint inhibitors （口頭発表） 2019/07/20
5件表示
全件表示(44件)